×

RNS Number : 0651W

Croma Security Solutions Group PLC

13 August 2020

 

 

13 August 2020

CROMA SECURITY SOLUTIONS GROUP PLC

("CSSG" or the "Group")

Reinstatement of Dividend and Contract Win

Croma Security Solutions Group Plc, the total security services provider, is pleased to announce the reinstatement of the Company's interim dividend. On 19 March 2020, as a precaution against the potential impact of Covid-19, the Company cancelled the interim dividend announced alongside the Interim Results. Having now completed the financial year to 30 June 2020, it is clear the impact of Covid-19 on Group has been light.

As a consequence, the Company intends to pay an interim dividend of 0.75p per share on 4 September 2020 to shareholders with an ex-dividend date of 20 August 2020 and an associated record date of 21 August 2020.

The Company is also pleased to confirm that post-year end, Croma Vigilant has won a guarding contract from Savills to manage the security for the Edinburgh St James centre. A £1 billion redevelopment, the centre is a major scheme in the heart of Edinburgh and is due to open in Spring 2021. The guarding contract is for 3 years, worth £1.3 million annually and commences from 2 April 2021.

The centre includes retail, commercial and residential buildings and under the new contract, Croma Vigilant will provide a range of its premium guarding services including PROception. Led by ex-policewoman Ruth McGowan, PROception was launched in 2019 and brings the amalgamation of 3 key disciplines: reception, concierge and security, to create the modern front of house professional.

Chairman, Sebastian Morley, said, "At the outbreak of the Covid-19 pandemic in March we took the decision to cancel the dividend until we gained greater visibility on the impact it might have. Pleasingly, the impact has been slight, due in part to the organisation and flexibility of our teams which maintained all services at full strength. Having now completed the financial year, we expect we will deliver a good financial performance and with no borrowings and record levels of cash we are comfortable in re-instating the interim dividend.

The Edinburgh St James centre security contract was a highly competitive tender and as a team we are delighted to have been chosen and believe our premium security services coupled with the range of additional capabilities we are able to provide were instrumental in securing this prestigious contract."

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For further information contact:

Croma Security Solutions Group plc Sebastian Morley, Chairman	Tel: +44 (0)7768 006 909
WH Ireland Limited (NOMAD and Broker) Mike Coe / Chris Savidge	Tel: +44 (0)207 220 1666
Novella Communications Tim Robertson / Fergus Young	Tel: +44 (0)203 151 7008

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

DIVKXLBFBVLZBBZ

Close

×

RNS Number : 9549V

N4 Pharma PLC

12 August 2020

 

12 August 2020

 

N4 Pharma plc

 

("N4 Pharma" or the "Company")

 

 

 Positive Covid-19 In Vitro Study Results

 

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce that Nuvec® loaded with Coronavirus plasmid has successfully transfected Human Embryonic Kidney ("HEK") cells in vitro and induced an expression of the spike protein in the cells.

 

This successful result is the second stage of the Company's three stage plan for its Covid-19 proof of concept research project being undertaken with Evotec International Gmbh ("Evotec") means that the project will now move into its third stage, being the pre in vivo study to demonstrate expression of the spike protein in target cells in a murine target.

 

Nigel Theobald, Chief Executive Officer of the Company, commented:

 

"We are delighted to have achieved in vitro transfection of HEK cells with Nuvec® loaded with coronavirus plasmid. We now move straight to the third stage of our Covid-19 project with our pre in vivo study at Evotec. The global pandemic continues to dominate all of our lives and we are extremely excited to be moving onto the next stage of our Covid-19 project, the successful outcome of which will determine our next work streams in this area and how we might collaborate with appropriate partners interested in any advantage our Nuvec® delivery system may provide. We look forward to providing updates on this project and our other work streams in due course."

 

Clarification note

 

In the Company's announcement of 16 April 2020, it stated the original intention to use murine peripheral blood mononuclear ("PBMC") cells for the in vitro study. However, when working with the PBMCs it was not possible to get a sufficient number to undertake all the experiments. As a result the in vitro work was done using HEK cells as detailed above.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

 

Enquiries:

 

N4 Pharma plc
Nigel Theobald, CEO	Via Scott PR
Luke Cairns, Executive Director
SP Angel Corporate Finance LLP	Tel: +44(0)20 3470 0470
Nominated Adviser and Joint Broker
Matthew Johnson/Caroline Rowe (Corporate Finance)
Vadim Alexandre/Abigail Wayne/Rob Rees (Corporate Broking)
Turner Pope Investments (TPI) Limited	Tel: +44(0)20 3657 0050
Joint Broker
Andy Thacker
Scott PR
Georgia Smith	Tel: +44(0)1477 539 539

 

 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCSFIFEEESSELA

Close

×

RNS Number : 2893V

Immotion Group PLC

06 August 2020

 

RNS Reach

 

Immotion Group plc

 

("Immotion Group", the "Company")

 

On back of demand, Immotion launches commercial UV cleaning solution – Uvisan

 

Immotion Group, the UK-based immersive entertainment group is pleased to announce, following its trading update of last week, the launch of a range of proprietary UV anti-bacterial cleaning cabinets, under the Uvisan brand.

 

As per the statement last week, as a direct response to the COVID-19 crisis the Company has designed and had exclusively manufactured a range of proprietary UV disinfectant cabinets. The new product was originally designed for the sole purpose of cleansing VR headsets for its larger partner locations, predominantly Shark Reef at Mandalay Bay, Las Vegas. The Company realised that the cleansing of VR headsets was going to be important to maximise both operational throughput as well as keep customers safe. Following the announcement last week, the Company has received numerous external commercial enquiries. As a direct result it has decided to sell the cabinets to third party companies under the Uvisan name.

 

Following exceptional demand, the Company in  the last week sold 10 cabinets, including four cabinets to Chichester University, who have purchased the cabinets to protect sensitive equipment against COVID-19 infection.

 

The University approached Uvisan as they quickly realised multimedia equipment such as microphones, laptops and speakers cannot be treated with traditional solution-based alcohol cleaning materials, and as such they needed a proven solution for this problem. The Uvisan cabinets provide a clinically proven alternative to protect students, staff and business partners. 

 

Chichester is the first University to be supplied by Uvisan, although we are starting to see enquiries from other academic faculties.

 

The cabinets are available in a variety of sizes with the largest able to accommodate, cleanse and charge up to 30 laptops in a matter of minutes. The Uvisan cabinets range in price from £2,399 to £3,199.

 

The Uvisan cabinet will provide Chichester University with medical-grade light spectrum cabinets that have been proven to kill 99.9% of all pathogens including virus and bacteria, removing the need for alcohol and solution based products that could harm sensitive technology.

 

The Company has tested the cabinets on a variety of equipment, including Motion capture suit components, Microphones, Keyboards, Cameras, PC peripherals, Headphones and VR headsets to name but a few items. Due to demand a UV clothing cabinet has now been designed with a view to supplying sectors where the cleansing of uniforms, and staff clothing is essential.

 

The Uvisan process works by harnessing ultraviolet germicidal irradiation (UVGI), which is a disinfection method that uses short-wavelength ultraviolet (ultraviolet C or UVC) light to kill or inactivate micro-organisms by destroying nucleic acids and disrupting their DNA,  leaving them unable to perform vital cellular functions. UVGI is used in a variety of applications, such as food, air, and water purification.

 

A cleaning cycle using UVGI takes between 3 to 10 minutes (dependent on the number of devices and object surface complexity) and can sanitise up to 100 phones, 50 tablets or 30 VR headsets in a single cycle.

 

Arek Antoniak, Operations Director – Immotion said: "When the pandemic hit we knew we had to find a solution for our larger VR Partners, our team set about designing a cabinet from scratch and within weeks had created and built the Uvisan range. All the cabinets have undergone extensive clinical testing and are proven to kill 99.9% of bacteria and viruses in a matter of minutes."

 

"The Uvisan solution is ideal for Universities, Schools, TV Studios and effectively any organisation where the use of a solution based cleansing method is not acceptable. We know many organisations need a guarantee that the equipment their staff and customers are using is safe – Uvisan can provide this level of comfort."

 

Rod Matthews from Chichester University said: "At the University of Chichester we take pride in ensuring our students have the safest as well as the best experience across everything we do. Our students can expect to have hands-on experience of high-tech equipment across our entire curriculum, and especially in our innovative eSports, eGames Design, Animation and Film Production facilities. In our state of the art Tech-Park, students get to use high-end industry filming equipment such as motion capture, as well our extensive bespoke computer labs to create and edit films, audio, animation to industry production standards."

 

"We needed a solution that was easy to use and would eradicate bacteria without damaging the sensitive equipment used by our colleagues and students. The Uvisan cabinet was the perfect proven solution allowing us to clean all our equipment in a simple and quick cleaning cycle."

 

 Enquiries:

 For further information please visit  www.immotion.co.uk , or contact: 

 

Immotion Group	Martin Higginson	Tel: +44 (0) 161 235 8505
WH Ireland Limited (Nomad and Joint Broker)	Adrian Hadden  Darshan Patel Matthew Chan	Tel + 44 (0) 207 220 1666
Shard Capital Partners LLP (Joint Broker)	Damon Heath Erik Woolgar	Tel: +44 (0) 20 7186 9900
Alvarium Capital Partners	Alex Davies	Tel: +44 (0) 207 195 1433

 

  About Uvisan – A member of the Immotion Group.

 

Uvisan is part of Immotion Group plc. The Uvisan cabinets are fully certified by ISO standards of manufacturing. Its product has been fully tested and certified in line with IEC 62471 Photobiological Safety Standards. The pathogen kill rate efficiency, as quoted in this release, has been confirmed by laboratory testing and result certificates are available upon request. Uvisan.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact  [email protected]  or visit  www.rns.com .

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAUPUBCRUPUGRA

Close

×

RNS Number : 2870V

Verditek PLC

06 August 2020

 

 

 6 August 2020

 

Verditek PLC

 

("Verditek" or the "Company")

 

Major order for its Industrial "Power in a Box" Solution

 

 Contract signed for six units totalling 1.5 MW of capacity

 

Verditek plc, (AIM:VDTK) the clean technology company, is delighted to announce, following its earlier successful completion of the first project in Pakistan, that it has received a further substantially larger follow-on order, for six containerised ultra-lightweight solar Power Matts , valued at US$2.2m. The order from SAF Group ('SAF") (www.safpakistan.com) marks a significant milestone for Verditek, as it represents major confirmation of the Company's  leading position in the large-scale, portable, rapidly deployable, ultra-lightweight solar market from a respected International group. SAF is a specialist International Engineering, Construction, Fabrication, Project Management company operating in the field of Oil & Gas, Oil Refining, Power Generation and Chemical Process Industries.

These panels will be supplied as an easily deployable containerised solution to provide temporary and semi-permanent power, further reducing the reliance on diesel fuel for their operations.

 

Importantly, SAF is also collaborating with the Regional Government of Sindh, Pakistan, to supply renewable clean energy to the province, and at least one of these containerised units is planned to be deployed for this purpose. This in turn could provide the opening for a whole new market for the Company, moving beyond the initial entry point in the oil and gas industry.

 

Ali Salman, MD of SAF Group, commented: "At SAF Group, we strive to be at the forefront of green technology in Pakistan. The use of the Verditek "power in a box" solution to replace diesel generators will contribute to our goal on both our own sites and as part of our collaboration with the Sindh Government, enables us to deploy this solution to bring clean energy to the people of Pakistan at a cost significantly lower than utilising traditional diesel".  

 

Robert Richards, CEO of Verditek, commented: " Verditek is proud and excited to have been chosen to supply its innovative, rapidly deployable power solution, which will  provide 250kW of power from each container.  This will be our first collaboration with the Government of Pakistan and demonstrates the trust they have in our technology to deliver green energy to a remote region of Pakistan.  This order moves us significantly towards my stated goal of achieving free cash flow within 2020."

Lord David Willetts. Chairman commented, "This new contract is very important not only because it represents a much larger follow on order from an existing customer, but because it takes the Company into a new arena, in working on clean energy supply at sovereign country level. This underlines the enormous global opportunity facing Verditek. 

 

Enquiries:

 

Verditek plc

 

RH Lord David Willetts FRS (Chairman)                                                                                  +44 (0) 20 7129 1110

Robert Richards (Chief Executive Officer)      [email protected]

 

 

WH Ireland Limited (NOMAD and Broker)

 

Chris Hardie (D irector, Corporate Finance)                                                                            +44(0)207 220 1666 

Matt Chan                                                                                                                [email protected]

 

About Verditek plc

AIM listed Verditek plc is a holding company with three businesses operating within the clean technology sector. The Company is focused on commercializing our lightweight low-profile solar panel business. With manufacturing based in Lainate Italy, we have developed renewable power solutions for our customers, that drive solar energy into applications previously impossible. The exceptional properties of our solar panels replace diesel fuel in business such as perishable goods transport, off-grid telecommunication towers, electric vehicle charging stations, residential and holiday home power solutions and solar roofing for light-weight industrial roofing. In addition to our current PV panels in production, we have partnered with an outstanding leader in graphene technology, Paragraf, and have created the worlds' first Graphene Integrated Photo Voltaic cell. We are working together to engineer the technology for commercialization.

 

Verditek provides compelling commercial solutions that make our customers business sustainable.

 

For more information please visit or contact the following:   https://verditek.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTDELFBBVLLBBX

Close

×

RNS Number : 8998U

British Honey Company PLC (The)

03 August 2020

 

03.08.20

 

 

The British Honey Company plc

("British Honey", "BHC" or the "Company")

 

Global Strategic Licensing and Distribution Agreement signed with English Heritage

 

The British Honey Company plc, the producer of premium British Honey-infused spirits and alcohol sanitiser products, is pleased to announce that it has signed a strategically important four-year Global Licensing and Distribution Agreement with English Heritage. English Heritage is a registered conservation charity which cares for over 400 historic monuments, buildings and places – from world famous prehistoric sites to grand medieval castles, from Roman forts on the edge of an empire to a Cold War bunker – through which, it brings the story of England to life for over 10 million visitors each year.

 

Under the terms of the Agreement, BHC will sell English Heritage branded and trademarked spirits, including gin, vodka, whisky and rum and low alcohol RTDs (Ready-to-Drink products) globally, utilising its established marketing and distribution online and direct sales channels, including into the United States which BHC sees as a key target market and where it has an existing collaboration with List Distillery of Florida, in which BHC has a 10% Shareholding and an agreement to purchase the remaining shareholding. This will facilitate direct access to List's extensive US distribution network.

 

BHC and English Heritage have an established trading relationship dating back to 2016 whereby English Heritage stocked BHC's Honey & Spirits. Subsequently, in 2020, BHC helped to develop and supply English Heritage with its "own label" St Clement's Gin and Elderflower & Rose Gin. BHC also supplies English Heritage with its own Keepr's honey and spirits range, sold through its onsite shops and online.

 

Commenting on the Licensing Agreement, BHC Commercial Director, Oliver Williams said:

"I am delighted to further develop our relationship with such a well-known and highly respected Partner. The English Heritage brand lends itself perfectly to our international marketing and distribution channels, further extending our global reach and we envisage significant opportunities to develop the brand over the next four years and beyond."

 

Kingston Myles, Head of Commercial Development at English Heritage added:

"This new license agreement will grow on an already well-established relationship with the

British Honey Company. We will see English Heritage reach global markets with a unique range

of premium products. We are excited to see this licensee join our portfolio and look forward to

seeing what the future holds."

 

Thomas List, CEO of List Distillery, Fort Myers USA added:

"We are excited to be part of the BHC's English Heritage branded craft spirits distribution channel in America. By combining high quality spirits with the history and culture of English HerItage, we can see great potential for these products in the US. I am convinced that this will be another successful example of BHC and List Distillery working closely together to create enhanced customer value."

 

 

 Enquiries:

British Honey Michael Williams, CEO Brooke Wiseman, Marketing Director	Tel: +44 (0)7976 559243 Email: [email protected] Web: https://britishhoney.co.uk/
finnCap – AQSE Corporate Adviser & Joint Broker Carl Holmes / Matthew Radley (corporate finance) Richard Chambers (ECM)	Tel: +44 (0)20 7220 0500
Stanford Capital Partners – Joint Broker Patrick Claridge / John Howes / Bob Pountney	Tel: +44 (0)20 3815 8880
Walbrook PR Limited – Financial PR Paul Vann / Nick Rome / Nicholas Johnson	Tel: +44 (0)20 7933 8780   +44 (0)7768 807631 [email protected]

 

Notes to Editors

 

About British Honey Company

 

Launched in 2014, BHC is famed for its award-winning fruit and honey infused spirits, marketed under the Keepr's brand. Many of the Keepr's spirits are infused with BHC's proprietary British Honey from its fully traceable apiaries. The impressive spirits range with seasonal lines spans eight gins, four vodkas, two rums, two bourbons and a whiskey which is scheduled for release later this year. All of BHC's spirits are distilled onsite in the company's specially customised Still.

 

BHC has won numerous industry awards for the quality of its spirits. Monday 20th july  the Company was awarded five  medals at The London Spirits Competition 2020, where Keepr's British Sloe and Honey,  Keepr's Honey  Spiced Rum and Dodds Gin received Silver Medals whilst Bronze awards went to Keepr's British Raspberry and Honey Gin and Keepr's Classic London Dry Gin with British Honey.

 

In March 2020 BHC diversified its product range by developing its first alcohol sanitiser product in the UK in response to the Covid-19 outbreak. This was produced using BHC's excess alcohol supplies and under authorisations obtained from HMRC to use denatured alcohol for alcohol sanitiser use.

 

About English Heritage  

 

English Heritage cares for over 400 historic buildings, monuments and sites – from world-famous prehistoric sites to grand medieval castles, from Roman forts on the edge of the empire to a Cold War bunker. Through these, we bring the story of England to life for over 10 million people each year. Registered charity no. 1140351. www.english-heritage.org.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NEXFZGGRKFFGGZG

Close

×

RNS Number : 3268T

Pennant International Group PLC

17 July 2020

 

 

 

FOR IMMEDIATE RELEASE    17 July 2020  

PENNANT INTERNATIONAL GROUP PLC

 

New Contract Award

'Statement of Intent' converted into initial £1.5 million Middle East Order

&

Notice of Half-Year Trading Update

 

Pennant International Group plc ("Pennant", the "Group", or the "Company), a leading global provider of technology-based maintainer training and integrated product support solutions, is pleased to announce the award of a new contract with an initial order value of £1.5 million.

The award follows the Company's announcement on 19 February 2020 that it had received a statement of intent for the purchase of training aids worth up to £5 million from a long-standing customer in the Middle East.

The training aids have been selected from Pennant's existing suite of generic products, with the majority of revenue on the order expected to be recognised in 2021 as the training aids are completed and delivered.

This new award takes the Group's contracted order book scheduled for 2021 to just under £13.5 million.

Following receipt of this initial order, the Company anticipates that the customer will make further purchases in line with the statement of intent and expects an additional order to be placed later this year or in early 2021.

Phil Walker (Group CEO) commented: "We are delighted to have secured this new contract, which is testament to our close and long-standing partnership with the customer. It also demonstrates the Group's continued ability to convert new opportunities and win new international business which is particularly important in the current economic climate".

The Group intends to provide a Trading Update on 13 August 2020 in respect of the six months ended 30 June 2020.

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

 

Pennant International Group plc	www.pennantplc.co.uk
Philip Walker, CEO	+44 (0) 1452 714 914
David Clements, Commercial & Risk Director
WH Ireland Limited (Nomad and Broker)	www.whirelandcb.com
Mike Coe Chris Savidge	+44 (0) 117 945 3470
Walbrook PR (Financial PR)	[email protected]
Paul Vann Tom Cooper	+44 (0)20 7933 8780 Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTFZGMNKNNGGZG

Close

×

RNS Number : 4531S

Elixirr International PLC

09 July 2020

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUE A VIOLATION OF THE SECURITIES LAWS OF THESE JURISDICTIONS.

For immediate release

9 July 2020

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Admission to Trading on AIM

and

First Day of Dealings

 

Elixirr, an established, global award-winning challenger consultancy, is pleased to announce the admission of its entire issued and to be issued ordinary share capital to trading on the AIM Market of the London Stock Exchange. Admission will occur at 8.00 a.m. today, under the ticker "ELIX" and the ISIN GB00BLPHTX84.

The Company has successfully raised £20.0 million (before expenses) by way of an oversubscribed placing of 9,216,590 new Ordinary Shares with institutional and other investors at a price of 217 pence per Ordinary Share (the "Placing Price"). In addition, 2,304,148 existing Ordinary Shares have been placed on behalf of the Selling Shareholders at the Placing Price, raising gross proceeds of £5.0 million.

The Company's market capitalisation at the Placing Price on Admission is £98.1 million. finnCap is acting as Nominated Adviser and sole Broker to the Company.

The Company's AIM admission document is available to view on the Company's website: www.elixirr.com .

 

Stephen Newton, Chief Executive of Elixirr International plc commented:

"Listing on AIM today marks an incredible chapter in Elixirr's story. The vision I had for the firm in 2009 remains – to become a world-leading consultancy. Admission to the exchange will further support our reputation as the challenger consultancy and provide the capital to accelerate our integrated strategy, growing off the great platform we have created.

This huge achievement is a culmination of the exceptional work and partnership with our fantastic clients, our talented team and our trusted advisors.

Everyone within the business is looking forward to beginning our life as a public company which will see all Elixirr employees become shareholders to further align the business for continued success. "

 

For further Information please contact:

 

Elixirr International plc Stephen Newton, CEO Graham Busby, CFO
Public and Investor Relations contacts: Caroline Pitt Jazz Berry   finnCap Ltd (Nominated Adviser & Sole Broker) Christopher Raggett, Simon Hicks, Kate Bannatyne (Corporate Finance) Andrew Burdis, Sunila De Silva (ECM)	[email protected]     +44 (0)20 7220 0500

About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

 

Important notices

Capitalised terms used in the Company's AIM admission document dated 6 July 2020 have the same meanings in this announcement.

finnCap which is authorised and regulated in the United Kingdom by the Financial Conduct Authority is acting exclusively for the Company and no one else in connection with the Placing and Admission, and finnCap will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing and Admission or any other matters referred to in this announcement.

Neither finnCap, nor any of its subsidiary undertakings, affiliates or any of its directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions contained in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith and any liability therefore is expressly disclaimed.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCRPMFTMTBMBBM

Close

×

Neville Registrars is delighted to welcome Elixirr International plc as the newest addition to its list of client companies.

 

Elixirr International is an established, global, award-winning management consultancy. Since its inception, Elixirr has worked with over 150 clients across numerous countries spanning Europe, North America, Africa, Asia and Australia, with offices in the UK and permanent presence (and employees) in the US and South Africa.

 

Further information can be found on the Company's website: https://www.elixirr.com/

Close

×

RNS Number : 9175R

Trakm8 Holdings PLC

03 July 2020

 

3 July 2020

 

TRAKM8 HOLDINGS PLC

 

('Trakm8' or 'the Group' or 'the Company')

 

Contract Award

 

Further to the announcement of 27th April, Trakm8 Holdings plc (AIM: TRAK), the global telematics and data insight provider, has now agreed the fleet optimisation contract with a major UK food retailer that had been expected in March but was delayed due to the COVID19 outbreak. The contract is initially for 2 years and utilises Trakm8's market leading algorithm to optimise home deliveries. There will be some initial customer funded engineering integration activity in advance of product going live later in the year.

 

– Ends –

 

 

For further information:

 

Trakm8 Holdings plc
John Watkins, Executive Chairman	Tel: +44 (0) 1675 434 200
Jon Furber, Finance Director	www.trakm8.com
Arden Partners plc (Nominated Adviser & Broker)	Tel: +44 (0) 20 7614 5900
Paul Shackleton	www.arden-partners.com

 

Notes to Editors

Trakm8 is a UK based technology leader in fleet management, insurance telematics, connected car, and optimisation. Through IP owned technology, the Group analyses data collected by its installed base of telematics units to fine tune the algorithms that are used to produce its' solutions; these monitor driver behaviour, identify crash events and monitor vehicle health to provide actionable insights to continuously improve the security and operational efficiency of both company fleets and private drivers.

 

The Group's product portfolio includes the latest data analytics and reporting portal (Trakm8 Insight), integrated telematics/cameras/optimisation, self-installed telematics units and one of the widest ranges of installed telematics devices. Trakm8 has over 245,000 connections.

 

Headquartered in Coleshill near Birmingham alongside its manufacturing facility, the Group supplies to the Fleet, Optimisation, Insurance and Automotive sectors to many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Iceland Foods, Scottish Power, Direct Line Group, LexisNexis and Ingenie.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005.

 

www.trakm8.com / @Trakm8

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTSSDFAEESSESW

Close

×

Neville Registrars is delighted to welcome Vintana plc as the newest addition to its list of client companies.

 

Vintana plc is classified as an AIM Rule 15 cash shell.

 

Further information can be found on the Company's website: http://www.vintana.uk/

Close